Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04075825 · ClinicalTrials.gov registry record · Phase 3
Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula
A Phase 3 study, sponsored by Takeda.
- Completed
- Registry status
- Phase 3
- Development phase
- 150
- Enrollment target
NCT04075825 is a Phase 3 study that has completed, run by Takeda. The registered enrollment target is 150 participants.
The verdict
NCT04075825, a Phase 3 study, has completed, sponsored by Takeda.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 150 participants
- Enrollment target
Study Summary
The main aim is to follow-up on long term side effect and symptom improvement of Darvadstrocel in the treatment of complex perianal fistula in adults. Participants will not receive any drug in this study.
Interventions
- OTHER Placebo
- BIOLOGICAL Darvadstrocel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-11-05 |
| Est. Completion | 2024-04-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04075825
The ClinicalTrials.gov registry entry for NCT04075825 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Takeda, which has 408 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT04075825 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04075825 about?
NCT04075825 is a clinical study titled "Long-term Follow-up Study With Darvadstrocel in the Treatment of Complex Perianal Fistula". The main aim is to follow-up on long term side effect and symptom improvement of Darvadstrocel in the treatment of complex perianal fistula in adults. Participants will not receive any drug in this study.
What is the current status of trial NCT04075825?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2019-11-05. Estimated completion is 2024-04-02.
What interventions are being tested in trial NCT04075825?
The interventions under investigation include: Placebo (OTHER), Darvadstrocel (BIOLOGICAL).
Who is sponsoring clinical trial NCT04075825?
This trial is sponsored by Takeda, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.